Intestinal Constipation
Conditions
Interventions
The volunteers will be divided into 2 groups.
Experimental group: 105 women will receive 15 sachets containing probiotic powder and will be given once daily diluted in water for 15 days. Placebo group
Dietary supplement
SP6.051.227
G07.203.300.456.500
Sponsors
Universidade Federal de Mato Grosso
Vitafor©
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women between the ages of 20 and 40; who are classified as constipated according to the ROME III criteria are; Maintain the same diet and routine of daily activities; and sign the Informed Consent Term.
Exclusion criteria
Exclusion criteria: Not to be classified as constipated according to the criteria of ROME III; Not sign the Free and Informed Consent Form; Abstain from treatment for one day; To change their eating routine or exercise during the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that after the use of probiotics the volunteers will have an improvement in intestinal function that will be evaluated through the ROMA III and CAS questionnaires at the beginning and end of the 15-day intervention. The data collected through applied questionnaires will be submitted to statistical analysis with a variation of at least 5% in the pre and post intervention measurements, and the expected intestinal constipation reduction in the experimental groups (sachet with probiotics) as compared to the control group (sachet placebo). | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that after the use of probiotics the volunteers will have an improvement in the quality of life that will be evaluated through the PAC-QOL questionnaire at the beginning and end of the 15-day intervention. The data collected through this questionnaire will be submitted to statistical analysis with a variation of at least 5% in the pre and post intervention measurements, and the expected quality of life improvement in the experimental groups (sachet with probiotics) as compared to the control group ( Placebo sachet). | — |
Countries
Brazil
Contacts
Public ContactCarlos;Carolina Fett;Novaes
NAFIMES Núcleo de Aptidão Física, Informática, Metabolismo, Esporte e Saúde;Vitafor©
Outcome results
None listed